HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line.

AbstractPURPOSE:
Resistance of neoplastic cells to the alkylating drug BCNU [1,3-bis(2-chloroethyl)-1-nitrosourea] has been correlated with expression of O (6)-methylguanine-DNA methyltransferase, which repairs the O (6)-chloroethylguanine produced by the drug. Other possible mechanisms of resistance include raised levels of glutathione or increased repair of the DNA interstrand cross-links formed by BCNU. Transcriptional profiling revealed the upregulation of several metallothionein (MT) genes in a BCNU-resistant medulloblastoma cell line [D341 MED (OBR)] relative to its parental line. Previous studies have shown that MTs, through their reactive thiol groups can quench nitrogen mustard-derived alkylating drugs. In this report, we evaluate whether MTs can also quench BCNU.
METHODS:
To demonstrate the binding of BCNU to MT, we used an assay that measured the release of the MT-bound divalent cations (Zn(2+), Cd(2+)) upon their displacement by the drug. We also measured the decomposition rates of BCNU at those reaction conditions.
RESULTS:
The rate of release of the cations was higher in pH 7.4 than at pH 7.0, which is likely a result of more rapid decomposition of BCNU (thus faster release of MT-binding intermediate) at pH 7.4 than at pH 7.0.
CONCLUSION:
We demonstrate that resistance to BCNU may be a result of elevated levels of MTs which act by sequestering the drug's decomposition product(s).
AuthorsManny D Bacolod, Randy Fehdrau, Stewart P Johnson, Nancy S Bullock, Darell D Bigner, Michael Colvin, Henry S Friedman
JournalCancer chemotherapy and pharmacology (Cancer Chemother Pharmacol) Vol. 63 Issue 4 Pg. 753-8 (Mar 2009) ISSN: 1432-0843 [Electronic] Germany
PMID18633619 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Metallothionein
  • Carmustine
Topics
  • Carmustine (metabolism)
  • Cerebellar Neoplasms (metabolism)
  • Drug Resistance, Neoplasm
  • Humans
  • Medulloblastoma (metabolism)
  • Metallothionein (metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: